Pharmacologic and Non-Pharmacologic Interventions for Hypothalamic Obesity: An Updated Review

Current Obesity Reports · Published 2026-07-24 · DOI 10.1007/s13679-026-00744-1

Authors (2)

Anna Zenno, Melinda Pierce

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zenno, A., Pierce, M. (2026). Pharmacologic and Non-Pharmacologic Interventions for Hypothalamic Obesity: An Updated Review. Current Obesity Reports. https://doi.org/10.1007/s13679-026-00744-1

Related articles

• Weight Loss Effect of Lisdexamfetamine in Children with Severe Obesity: A Case Series · Childhood Obesity · 2025 · Cites or is cited by this article
• Setmelanotide for the Treatment of Acquired Hypothalamic Obesity · New England Journal of Medicine · 2026 · Cites or is cited by this article
• Diagnostic criteria for acquired hypothalamic obesity – international expert guidance document · Endocrine Journal · 2025 · Cites or is cited by this article
• Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity · Endocrine Reviews · 2025 · Cites or is cited by this article
• Cross-Sector Policies for Achieving Equitable Obesity Prevention and Food Security: A Review of Real-World Actions · Current Obesity Reports · 2026 · Same journal
• Emotional Eating and Obesity: An Update and New Insights · Current Obesity Reports · 2025 · Same journal
• Intersection between Eating Disorders and Obesity in Youth: Implications for Treatment · Current Obesity Reports · 2025 · Same journal
• The Role of Fathers in the Intergenerational Transmission of Obesity · Current Obesity Reports · 2026 · Same journal
• Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver Disease · Current Obesity Reports · 2026 · Same journal
• Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat · Current Obesity Reports · 2026 · Same journal